HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

Australia Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


Australia Radiopharmaceutical Synthesizer Market Insights

  • As highlighted in Reed Intelligence analysis, the Australia Radiopharmaceutical Synthesizer Market, worth USD 45.38 Million in 2024, is forecasted to achieve USD 66.05 Million by 2033.
  • The Australia market is anticipated to grow at a CAGR of 4.26% during the period 2026–2033.
  • By 2024, PET represented the largest share of the Modality market size.
  • Others is expected to remain the key growth driver within Modality, registering the fastest CAGR during the forecast period.

Other Key Findings


  • Australia contributed 1.45% to the global Radiopharmaceutical Synthesizer Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Radiopharmaceutical Synthesizer Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2033.
  • Among Asia Pacific markets, Singapore is expected to post the fastest growth, reaching USD 27.98 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 45.38 Million
Market Size In 2033 USD 66.05 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.26% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports